Since the late 1980s, Mr. Rein has handled a wide variety of IP matters, particularly in the life sciences. Many of these matters involved cutting-edge technologies and/or the use of sophisticated analytical techniques. See, e.g., Merck Sharp & Dohme Corp. v. Teva Pharmaceuticals USA, Inc., 217 F.Supp.3d 782 (D. Del. 2016) (Trial victory relating to a generic version of NASONEX based on Mr. Rein’s examination of the parties’ expert witnesses including Merck’s expert who used one of the world’s most powerful X-ray diffraction facilities, the synchrotron at Argonne National Laboratory, in an unsuccessful attempt to prove infringement).
Mr. Rein speaks Hebrew which he studied at Kibbutz Kfar Ruppin (an Ulpan in conjunction with the University of Haifa) and at the Hebrew University of Jerusalem. He also studied Modern Standard Arabic at Columbia University and Middlebury College, where he received a Conoco scholarship, as well as at New York University, where he was the recipient of a university fellowship.
Mr. Rein is currently serving on the Patents Committee of the New York City Bar Association, the Israel Practice committee of the American Intellectual Property Law Association and the Tech Division committee of UJA.